Taltz

N/A

Manufactured by Eli Lilly and Company

51,523 FDA adverse event reports analyzed

Last updated: 2026-05-19

About Taltz

Taltz is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Eli Lilly and Company. The most commonly reported adverse reactions for Taltz include INJECTION SITE PAIN, DRUG INEFFECTIVE, PSORIASIS, INJECTION SITE ERYTHEMA, INJECTION SITE REACTION. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for Taltz.

Top Adverse Reactions

INJECTION SITE PAIN3,866 reports
DRUG INEFFECTIVE3,217 reports
PSORIASIS3,205 reports
INJECTION SITE ERYTHEMA2,178 reports
INJECTION SITE REACTION1,773 reports
INJECTION SITE SWELLING1,637 reports
INCORRECT DOSE ADMINISTERED1,165 reports
PRODUCT DOSE OMISSION ISSUE940 reports
COVID 19920 reports
PAIN891 reports
ARTHRALGIA874 reports
THERAPY INTERRUPTED826 reports
DIARRHOEA817 reports
RASH814 reports
INJECTION SITE PRURITUS788 reports
PRURITUS787 reports
PSORIATIC ARTHROPATHY766 reports
NAUSEA755 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION673 reports
INJECTION SITE URTICARIA665 reports
FATIGUE655 reports
NASOPHARYNGITIS643 reports
INJECTION SITE MASS609 reports
OFF LABEL USE603 reports
INJECTION SITE HAEMORRHAGE600 reports
HEADACHE570 reports
INJECTION SITE RASH537 reports
MALAISE531 reports
URTICARIA525 reports
INFECTION506 reports
SINUSITIS499 reports
INJECTION SITE WARMTH488 reports
INJECTION SITE BRUISING476 reports
CONDITION AGGRAVATED462 reports
HYPERSENSITIVITY454 reports
PNEUMONIA443 reports
ILLNESS437 reports
PYREXIA433 reports
URINARY TRACT INFECTION416 reports
INFLUENZA402 reports
THERAPY CESSATION399 reports
DEATH374 reports
DRUG HYPERSENSITIVITY365 reports
CELLULITIS354 reports
ERYTHEMA349 reports
ARTHRITIS346 reports
PAIN IN EXTREMITY334 reports
TREATMENT FAILURE333 reports
ALOPECIA323 reports
PERIPHERAL SWELLING307 reports
THERAPEUTIC PRODUCT EFFECT DECREASED294 reports
VOMITING289 reports
COUGH279 reports
DIZZINESS273 reports
JOINT SWELLING266 reports
DYSPNOEA264 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE257 reports
EAR INFECTION250 reports
UNDERDOSE250 reports
UPPER RESPIRATORY TRACT INFECTION249 reports
DRUG INTOLERANCE242 reports
OROPHARYNGEAL PAIN241 reports
OVERDOSE232 reports
BRONCHITIS231 reports
THERAPY NON RESPONDER230 reports
HYPERTENSION226 reports
PRODUCT DOSE OMISSION226 reports
WEIGHT DECREASED225 reports
FALL222 reports
ABDOMINAL PAIN220 reports
FUNGAL INFECTION216 reports
BACK PAIN211 reports
MUSCULOSKELETAL STIFFNESS209 reports
ABDOMINAL DISCOMFORT204 reports
ACCIDENTAL UNDERDOSE203 reports
HERPES ZOSTER194 reports
PRODUCT USE ISSUE194 reports
ABDOMINAL PAIN UPPER193 reports
SWELLING189 reports
INJECTION SITE INDURATION185 reports
INFLAMMATION182 reports
FEELING ABNORMAL179 reports
GASTROINTESTINAL DISORDER179 reports
DEPRESSION169 reports
GAIT DISTURBANCE169 reports
MATERNAL EXPOSURE DURING PREGNANCY166 reports
ORAL CANDIDIASIS165 reports
ANXIETY164 reports
MYOCARDIAL INFARCTION162 reports
DRUG DOSE OMISSION161 reports
ASTHENIA158 reports
RHEUMATOID ARTHRITIS158 reports
INSOMNIA157 reports
INFLUENZA LIKE ILLNESS155 reports
CANDIDA INFECTION153 reports
WEIGHT INCREASED153 reports
SKIN EXFOLIATION152 reports
MYALGIA151 reports
STRESS149 reports
CHEST PAIN147 reports

Report Outcomes

Out of 36,290 classified reports for Taltz:

  • Serious: 7,662 reports (21.1%) — includes hospitalization, disability, life-threatening events, or death
  • Non-Serious: 28,628 reports (78.9%)
Serious 21.1%Non-Serious 78.9%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female20,151 (61.0%)
Male12,895 (39.0%)
Unknown12 (0.0%)

Reports by Age

Age 55654 reports
Age 60651 reports
Age 56630 reports
Age 58607 reports
Age 63596 reports
Age 54562 reports
Age 59561 reports
Age 62561 reports
Age 50556 reports
Age 61556 reports
Age 64551 reports
Age 53550 reports
Age 57529 reports
Age 52526 reports
Age 65525 reports
Age 51480 reports
Age 49438 reports
Age 45428 reports
Age 48405 reports
Age 44403 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with Taltz?

This profile reflects 51,523 FDA FAERS reports that mention Taltz. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for Taltz?

Frequently reported terms in FAERS include INJECTION SITE PAIN, DRUG INEFFECTIVE, PSORIASIS, INJECTION SITE ERYTHEMA, INJECTION SITE REACTION, INJECTION SITE SWELLING. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures Taltz?

Labeling and FAERS entries often list Eli Lilly and Company in connection with Taltz. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.